Activity of aztreonam-avibactam and comparators against difficult-to-treat resistant Enterobacterales from United States medical centres (2020-24) <sup>†</sup>. [PDF]
Sader HS +4 more
europepmc +1 more source
Revisão do perfil epidemiológico da resistência ao Cefiderocol : desafios frente a bactérias multirresistentes [PDF]
Orientadora: Prof.ª Dra. Fabiana Caroline Zempulski VolpatoArtigo (bacharelado) - Universidade Federal do Paraná, Setor de Palotina, Curso de Graduação em Ciências BiológicasInclui referênciasResumo: A resistência bacteriana (RAM) é um perigo eminente à ...
Ricken, Luana Cristine
core
Genomic and Clinical Features Associated With Reduced Susceptibility to Cefiderocol and Cross-Resistance to β-Lactam/β-Lactamase Inhibitors in a Global Cohort of Pseudomonas aeruginosa. [PDF]
Egge SL +12 more
europepmc +1 more source
In vitro activity of cefiderocol against Burkholderia cepacia complex and Burkholderia gladioli clinical isolates from cystic fibrosis patients in the United States. [PDF]
Mojica MF +6 more
europepmc +1 more source
International audienceBackground : Achromobacter spp. are opportunistic pathogens, mostly infecting immunocompromised patients and patients with cystic fibrosis (CF) and considered as difficult-to-treat pathogens due to both intrinsic resistance and the ...
Guinard, Jérôme +26 more
core +1 more source
A Descriptive Observational Study of Real-Time TDM-Guided Aggressive PK/PD Target Attainment and Microbiological/Clinical Outcome in Patients with <i>Stenotrophomonas maltophilia</i> Bloodstream Infections and/or Pneumonia Treated with Continuous Infusion Cefiderocol. [PDF]
Gatti M +5 more
europepmc +1 more source
Unlabelled: The impact of chromosomally encoded wild-type or extended-spectrum (ESAC) AmpC β-lactamases of Escherichia coli on susceptibility to ceftazidime, cefepime, and cefiderocol was evaluated in different genetic backgrounds, including wild-type ...
Raro, Otávio Hallal Ferreira +3 more
core +1 more source
Clinical characteristics, molecular features and <i>in vitro</i> susceptibility to sulbactam-durlobactam, cefiderocol, and eravacycline in NDM-1-producing versus OXA-23-producing carbapenem-resistant <i>Acinetobacter baumannii</i> isolates from children in Guangxi, China. [PDF]
Liu M, Li M, Yan C, Huang L, Zhang H.
europepmc +1 more source
In Vitro Activity of Eravacycline, Aztreonam-Avibactam, and Cefiderocol Against Multidrug-Resistant Gram-Negative Clinical Isolates from a Romanian Tertiary Hospital. [PDF]
Baicus A +6 more
europepmc +1 more source

